The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | Challenges in the treatment and management of ET and the need to improve therapeutic approaches
Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, shares some insights into the challenges of treating and managing essential thrombocythemia (ET), and further discusses the biology behind ET and polycythemia vera (PV). Prof. Spivak also shares some thoughts on how to approach the treatment of these diseases. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
